Ionis Pharmaceuticals Inc - Company Profile
Powered by
All the data and insights you need on Ionis Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Ionis Pharmaceuticals Inc Strategy Report
- Understand Ionis Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ionis Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3880211A4 | Search Report | MODULATOREN DER FOXP3-EXPRESSION | A61K31/711; A61K31/7125; A61K31/713; A61P35/00; C07H21/00; C12N15/113; C12N2310/11; C12N2310/14; C12N2310/315; C12N2310/321; C12N2310/3231; C12N2310/3341; C12N2310/34; C12N2310/341; C12N2310/344; C12N2310/3525 | September 21, 2022 |
EP4056703A1 | Application | VERFAHREN ZUR MODULIERUNG DER MECP2-EXPRESSION | A61K31/7125; C12N15/113; C12N2310/11; C12N2310/315; C12N2310/322; C12N2310/3341; C12N2310/341; C12N2310/346; C12N2320/32 | September 14, 2022 |
EP4054655A1 | Application | VERBINDUNGEN UND VERFAHREN ZUR VERRINGERUNG DER SPDEF-EXPRESSION | A61K31/712; A61K31/7125; A61K47/02; A61K9/0073; A61P11/00; C07H21/04; C12N15/113; C12N2310/11; C12N2310/14; C12N2310/315; C12N2310/3231; C12N2310/341; C12N2310/346; C12N2310/351; C12N2320/11 | September 14, 2022 |
WO2022187312A1 | Application | PURIFICATION METHODS FOR OLIGOMERIC COMPOUNDS | September 09, 2022 | |
AU2021225957A1 | Application | Compounds and methods for modulating SMN2 | A61K31/712; A61K31/7125; A61K31/713; C12N15/113; C12N2310/11; C12N2310/315; C12N2310/321; C12N2310/322; C12N2310/3341; C12N2310/345; C12N2310/346; C12N2310/3515; C12N2320/33 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer